Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias2nd Department of Obstetrics and Gynecology, University of Athens, Aretaieio Hospital, GreeceAbstract: Zoledronic acid is a nitrogen-containing, third-generation bisphosphonate that has recently been approved for th...
Guardado en:
Autores principales: | Irene Lambrinoudaki, Sophia Vlachou, Fotini Galapi, Dimitra Papadimitriou, K Papadias |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60bce27397b64a8289a909232d2b0ec5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Once-yearly zoledronic acid in hip fracture prevention
por: Oddom Demontiero, et al.
Publicado: (2009) -
Nonpharmacological prevention of osteoporotic fractures
por: Cathy R Kessenich
Publicado: (2007) -
Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
por: Shi C, et al.
Publicado: (2018) -
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011) -
Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis
por: María J Moro-Álvarez, et al.
Publicado: (2008)